Suppr超能文献

金纳米颗粒给药途径对其组织分布及基本生化参数的影响:体内研究

The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies.

作者信息

Bednarski Marek, Dudek Magdalena, Knutelska Joanna, Nowiński Leszek, Sapa Jacek, Zygmunt Małgorzata, Nowak Gabriel, Luty-Błocho Magdalena, Wojnicki Marek, Fitzner Krzysztof, Tęsiorowski Maciej

机构信息

Department of Pharmacological Screening, Chair of Pharmacy, Jagiellonian University, Medical College, Kraków, Poland.

Department of Pharmacological Screening, Chair of Pharmacy, Jagiellonian University, Medical College, Kraków, Poland.

出版信息

Pharmacol Rep. 2015 Jun;67(3):405-9. doi: 10.1016/j.pharep.2014.10.019. Epub 2014 Nov 8.

Abstract

BACKGROUND

The gold nanoparticles (AuNP's) exhibit interesting chemical and physical properties and for this reason are intensively tested in medicine. However there is a lack of information about toxicity of those nanoparticles as well as their excretion from the body. Thus, the aim of the present study was to investigate the influence of the route of administration of gold nanoparticles to rats on their distribution in tissues and excretion rate.

METHODS

The experiment was carried out on male Wistar rats. The colloidal gold suspension containing 0.3619 mg of particles per milliliter, was administered per 1 kg of body weight. Serum levels of alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, glucose and ferric reducing ability of plasma were measured in all investigated animals.

RESULTS

It was shown that after oral administration only a small amount of AuNPs was absorbed. In addition, excretion of the metal during consecutive days after po or iv administration was examined. Moreover, the impact of AuNPs on some biochemical parameters 3 days after intravenous administration was studied. It was shown that the AuNPs are mainly cumulated in the liver, lungs and in spleen after iv administration and only slightly removed from the body in urine and feces.

CONCLUSION

Accumulation of those nanoparticles effect in increases of FRAP and glucose level up to 27% and 73%, respectively. This in turn suggests that iv administration of AuNPs may effect in serious medical complications. On the other site, the accumulation in the liver of about 50% of introduced particles to the rats body is promising for phototherapy and it opens "door" for drug transport to this organ.

摘要

背景

金纳米颗粒(AuNP's)具有有趣的化学和物理性质,因此在医学领域得到了广泛的测试。然而,关于这些纳米颗粒的毒性以及它们从体内排出的信息却很缺乏。因此,本研究的目的是探讨给大鼠施用金纳米颗粒的途径对其在组织中的分布和排泄率的影响。

方法

实验在雄性Wistar大鼠身上进行。每1千克体重给予含有每毫升0.3619毫克颗粒的胶体金悬浮液。在所有研究的动物中测量血清谷丙转氨酶、谷草转氨酶、总胆固醇、甘油三酯、葡萄糖和血浆铁还原能力水平。

结果

结果表明,口服给药后只有少量的金纳米颗粒被吸收。此外,还检查了口服或静脉注射后连续几天金属的排泄情况。此外,还研究了静脉注射3天后金纳米颗粒对一些生化参数的影响。结果表明,静脉注射后金纳米颗粒主要积聚在肝脏、肺和脾脏中,仅少量通过尿液和粪便从体内排出。

结论

这些纳米颗粒的积累分别使FRAP和葡萄糖水平升高了27%和73%。这反过来表明静脉注射金纳米颗粒可能会导致严重的医学并发症。另一方面,大约50%引入大鼠体内的颗粒在肝脏中的积累对光疗很有前景,并且为药物输送到该器官打开了“大门”。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验